Company news

Ondine Biomedical, Inc. (LSE:OBI) news

Every Ondine Biomedical, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Ondine Biomedical, Inc. stock analysis →

Press releases & updates

Major Scottish Hospital Adopts Steriwave

July 30, 2026

Keynote Address at 8th Annual Photodynamic Day

July 1, 2026

Leeds drops SSI 78% over Mupirocin with Steriwave

June 30, 2026

Update on US Phase 3 Pivotal Study

June 22, 2026

Leeds Drops SSIs by 78.5% in Complex Brain Surgery

June 18, 2026

Grant of Options and RSUs, and Issue of Warrants

June 8, 2026

2025 Full Year Results and Annual Report

June 4, 2026

Steriwave ICU Study Outcomes Presented at CSRT2026

May 26, 2026

Notification of major holdings - hInsight-NX, LLC

May 6, 2026

Ondine Presented Steriwave Data at IPC 2026

April 30, 2026

Proposed c.£5 million (C$9.23 million) Fundraise

April 28, 2026

ICU Study to be Presented at 2026 CACCN Conference

April 27, 2026

Marked Reduction in SSIs at Ottawa Heart Institute

April 23, 2026

Two Abstracts Accepted at World Congress

April 22, 2026

Steriwave ICU Study Shows 39.5% Pneumonia Drop

April 14, 2026

Business Update

April 13, 2026

ICU Study Accepted for Publication

April 8, 2026

Holdings in Company

March 24, 2026

Ondine Provides Update on US Phase 3 Pivotal Study

March 10, 2026

Share Issuance for ICU Study Submission

February 25, 2026

Holding(s) in Company

February 20, 2026

Ondine and Mid Yorks Win National Award

February 6, 2026

Steriwave Up for 2025 “Product of the Year” Award

February 2, 2026

Expanding Steriwave Use Across Vancouver Island

January 27, 2026

Steriwave Expands into ENT Surgery in Spain

January 22, 2026

New Independent Study Supports Photodisinfection

January 13, 2026

Finalist for 2nd National Award for SSI reduction

December 23, 2025

First German Hospital Pilots Steriwave

December 22, 2025

Ondine shortlisted for HSJ Partnership Award

December 16, 2025

Topline Results Significant in Steriwave ICU Study

October 27, 2025

Cambridge’s Papworth Hospital Pilots Steriwave

October 2, 2025

Ondine Biomedical Continues Growth in H1 2025

September 26, 2025

Steriwave Now Protecting Patients with Cancer

September 23, 2025

Notice of Interim Results & Investor Presentation

September 19, 2025

Ondine Presents Major Economic Benefits at ICPIC

September 18, 2025

Steriwave proven to be effective against C Auris

September 15, 2025

Grant of Options

September 12, 2025

Steriwave Featured on CNBC’s Worldwide Exchange

September 10, 2025

Notification of major holdings - hInsight

September 8, 2025

Notification of major holdings - Pentwater

September 4, 2025

Ondine to present Health Economic Data at ICPIC

September 3, 2025

Total Voting Rights Correction

September 1, 2025

Result of Fundraise & TVR

August 28, 2025

Proposed c.£11m Fundraise

August 27, 2025

First Mexican Hospital Steriwave Deployment

August 13, 2025

Ex-President of Mexico Champions APDT to Cut AMR

August 11, 2025

Share Issuance for ICU Study Enrollment Completion

July 22, 2025

UK Axes Financial support for AMR Fleming Fund

July 21, 2025

Growing Use of Steriwave Across Surgery Types

July 14, 2025

Steriwave in Half of Fraser Health Hospitals

July 8, 2025

Older →